Eagle Veterinary Technology Co.ltd. · KRX:044960
Eagle Veterinary Technology Co.ltd — Investor Presentation (2025)
26 slides from Eagle Veterinary Technology Co.ltd's investor presentation, 2025
Slide 1: Eagle Vet: The Leader of Animal Health Product
www.eagievet.com iz EAGLE VET The Leader of Animal Health Product
Slide 2: Disclaimer
EAGLE VET www.eaglevet.com DISCLAIMER BABE O27] BUY SAT}SOl| AAS ASO | Ps} SAO z apysigon, Sxergys EBSD QA] YSLICL S AEE Olayol| CHE OF AZ} HBISIO} QOH, oO} wHAEe! gixHo| AJBALRITh SAC] ABS SS Test Wow oss oo] wis; SO giajo] Yojate} zo} Ue} WZAlso] BANE + YES SvtstA)2| HIEILICh, 2 X}RO| RYE YL vA Fo
Slide 3: Table of Contents
PE OF CONTEN = Company Overview @ Core Business @ Growth Strategy m@ Appendix
Slide 4: EU-GMP, a powerful driving force for growth
Acquisition of EU-GMP Approval EU-GMP, a powerful The First in Korean Animal driving force for growth Pharmaceutical Industry Quality-proven production facilities and excellent quality control Certified aseptic injection manufacturing method of the world's best ※ EU-GMP (European Union Good Manufact
Slide 5: Eagle Vet, the Leading Animal Health Care Company in Korea
‘Eagle Vet’, the Leading Animal Health Care Company in Korea About Us History of Growth Business Portfolio Production Infrastructure
Slide 6: About Us
© @ @ company overview | 01-1 | About Us °° 06 A New Leap Forward Made By 50 Years Of Know-how, Eagle Vet The first-generation artisan company having led the domestic vet medicine market EAGLEVET Company Name Eagle Vet. Tech. Co., Ltd. CEO Kang, Seung Jo/ Kang, Tae Sung Founding date October 5*", 19
Slide 7: History of Growth
| 01-2 | History of Growth Nascent Stage (1970~1999) Founding Stage (2000~2008) Take-off Stage Growth Stage 2009 • Awarded $3M Export Tower 2017 • 1970 • 2000 • • Awarded as the Best Exporting Company 1983 • from the Minister of MAFRA • 1990 • • • Certified as a Corporate R&D Institute 2020 • 2010 2
Slide 8: Business Portfolio
© @ @ company overview +00 08 | 01-3 | Business Portfolio Portfolio-Diversification To Build Business Stability By creating sustainable business strategy CORE EXPANSION Veterinary Medicine Winning domestic market in providing prernium pet Pet Food Distribution Leading domestic drug market with a 50-
Slide 9: Production Infrastructure
| 01-4 | Production Infrastructure 3F Tablet compression 3F Oral Liquids manufacturing & Quality-Control lab 2F Liquids & Solids Injectables & Oral Liquids External Liquids & 2F Powder manufacturing Injectable Liquids & Powder manufacturing ■ Date of Foundation : Nov. 2014 ■ Dimension: 8,489.85㎡ ■ L
Slide 10: Eagle Vet, Preparing New Wings Through Continuous Efforts
Eagle Vet, Preparing New Wings Through Continuous Efforts Strengthening The Pipeline Expansion Into African Market Expansion Into China Market Building Premium Brands R&D, Strategic Partnership
Slide 11: Strengthening The Pipeline
| 02-1 | Strengthening The Pipeline Products Line Generic Line New Drug & IMD Natural Medicine 5 Groups, 200SKU A variety of 10 generics under Launching drugs for fish and bees Development of natural development in the years of 2024’ - 25’ ingredients & eco-friendly treatments for bees Additives/Pow
Slide 12: Expanding Into African Market
| 02-2 | Expanding Into African Market • Distribution of vet medicines, vaccines, and feed additives through • EAGLEVET UGANDA • • Introduction and development of advanced poultry farming business • through KOICA IBS project in Uganda • • Expanding sales networks through equity investment in animal
Slide 13: Expansion Into China Market
China China • Capital : Beijing • Population : 1.4 Biillion - World No. 2 • GDP : 17.7 Trillion dollars - World No. 2 China Market Sales Target • As of 2023, the global vet medicine market size accounted for 53T KRW 3500000 • In Korea, the market was valued at 1.4T KRW 3,000,000 3000000 (Unit: US$)
Slide 14: Building Premium Brands
| 02-4 | Building Premium Brands Organic Holistic Pet Food Hierarchy by Quality Organic pet food made with high-quality ingredients Super Premium Organic Top Holistic Officially certified by the Canadian and US Department of Agriculture Exclusive supplier of the multinational corporation, Good Super
Slide 15: R&D Partnerships
Generic & natural product research Cultivating relationships with partners • Research on new generics to increase market share Partner with superior technology & new material development methods R&D • Focusing on the development of fast-growing & high value- ships added pet medicines
Slide 16: Growth Strategy & Vision
Eagle Vet, Leaping Forward To A Global Leader Global Market Expansion New Growth Engine Veterinary Medicines CMO Direct to Consumer (DTC) Pet Food Increase Supply of Vet Medicines Growth Strategy & Vision
Slide 17: Global Market Expansion
© @ @ Growth strategy | 03-1 | Global Market Expansion Setting-out To Global Markets With EU-GMP Approval Expanding beyond with proactive marketing localization SOUTHEAST ASIA EARLY MARKET DEVELOPMENT WITH MULTINATIONAL COPORATIONS * Direct supply to local subsidiaries and multinational corporation
Slide 18: Increasing Market Share Through Active Market Development
Increasing Market Share Through Active Market Development Breaking into new markets and increasing market share through product portfolio management and active marketing campaign • • • • • • •
Slide 19: Veterinary Medicines CMO
@ Growth Strategy ° 19 | 03-3 | Veterinary Medicines CMO Breaking Into CMO MARKET With Competitive Production Facilities Expert positioning in veterinary medicine CMO market Expanding into CMO business Selling high value-added products through CMO agreement Building strong partnerships with global m
Slide 20: Leading In Premium Market Through Upgraded Distribution Channels
Leading In Premium Market Through Upgraded Distribution Channels “Building customer-friendly brand image for pet animal business-Haruwell” Upgraded Distribution Channels Refining current distribution channels Carving out new distribution channels Strengthening sales territory capabilities and Allian
Slide 21: Increase Supply of Vet Medicines
© @ @ Growth Strategy e021 | 03-5 | Increase Supply of Vet Medicines Diversifying Product Portfolio & Increasing Supplies Through Strong Networks Building up synergy with pet food distribution business @® Kidney Disease Solution @@ Strategic partnership with leading wholesaler * Chronic Kidney Disea
Slide 22: To be a Total Animal Healthcare Company
To be a Total Animal Healthcare Company by providing the best solutions for animal pharmaceuticals and pet care Leader of the Veterinary Pharmaceutical Leading Pioneer of the Overseas Leader of the Pet Industry Industry CMO Market Providing the best solutions (medicines, food, services) for pets
Slide 23: Mission, Vision, Core Value
@ Growth Strategy EAGLE VET'S MISSION, VISION, CORE VALUE MISSION To contribute to improving the quality of human life by providing comprehensive solutions (medicines, food & EAG a= VET services) to protect animals from diseases and ensure their healthy lives VISION To pursue the goal of becoming a
Slide 24: Business Performance
Business Performance
Slide 25: Business Performance
© @ @ Appendix 0025 Business Performance Summary Balance Sheet (Unit 100M KRW) Summary Income Statement (Unit : 100M KRW) 2024 2023 2022 2024 2023 2022 Current Assets 281 264 262 Sales a7 428 435 Non-Current Assets 331 321 286 Sales Cost 277 282 287 Total Assets 612 585 548 Current Liability 101 98
Slide 26: Investor Relations
2025 Investor Relations EAGLE VET The Leader of Animal Health Product www.eaglevet.com
Eagle Veterinary Technology — Investor Presentation (2025) on 6ix